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towards minimally-invasive, 
quantitative assessment of chronic 
kidney disease using optical 
spectroscopy
Mostafa e. Belghasem  1, ousama A’amar2, Daniel Roth1, Joshua Walker3, Nkiruka Arinze1,4, 
sean M. Richards3, Jean M. Francis3, David J. salant  3, Vipul C. Chitalia1,3,6 & Irving J. Bigio2,5
the universal pathologic features implicated in the progression of chronic kidney disease (CKD) are 
interstitial fibrosis and tubular atrophy (IFTA). Current methods of estimating IFTA are slow, labor-
intensive and fraught with variability and sampling error, and are not quantitative. As such, there is 
pressing clinical need for a less-invasive and faster method that can quantitatively assess the degree 
of IFtA. We propose a minimally-invasive optical method to assess the macro-architecture of kidney 
tissue, as an objective, quantitative assessment of IFTA, as an indicator of the degree of kidney disease. 
The method of elastic-scattering spectroscopy (ESS) measures backscattered light over the spectral 
range 320–900 nm and is highly sensitive to micromorphological changes in tissues. Using two discrete 
mouse models of CKD, we observed spectral trends of increased scattering intensity in the near-UV 
to short-visible region (350–450 nm), relative to longer wavelengths, for fibrotic kidneys compared 
to normal kidney, with a quasi-linear correlation between the ESS changes and the histopathology-
determined degree of IFTA. These results suggest the potential of ESS as an objective, quantitative 
and faster assessment of IFtA for the management of CKD patients and in the allocation of organs for 
kidney transplantation.
Close to 10 million Americans have chronic kidney disease (CKD)1, which is characterized by the presence of 
tubulointerstitial fibrosis (IF) and tubular atrophy (TA) (IFTA). IFTA is a universal pathologic feature impli-
cated in the progression of CKD, irrespective of inciting cause2,3 and correlates strongly with renal survival in 
humans and also guides therapeutic decisions4. Thus, accurate quantification of IFTA is clinically important, yet 
current methods of estimating IFTA have several limitations. Ultrasonic measurement of kidney size and the 
echo texture is used for such purposes, but it is a crude tool that only becomes sensitive when the kidneys have 
already begun to shrink in size and become denser because of tubular atrophy and replacement with fibrous tis-
sue. Elastography, a technique that has proven valuable for detecting and quantifying liver fibrosis, cannot be used 
to detect and measure kidney fibrosis because the kidneys, as opposed to the liver, are deeply embedded in the 
abdominal cavity, with thick muscle layers behind and bowel in front. While several MRI-based methods such as 
diffusion-weighted MRI, BOLD MRI, MR elastography, and renal susceptibility imaging have been investigated 
to assess severity of renal fibrosis, these techniques have limited accuracy or are confounded by the deep position 
of the kidneys in the retroperitoneal space covered by muscles, resulting in contradictory results5.
Among the options, an IFTA estimate derived from histological assessment of a kidney biopsy is widely 
accepted as the gold standard and is the current clinical practice. This method is slow, labor-intensive and fraught 
with variability and sampling error. It provides a semi-quantitative estimate, which is derived from one compo-
nent of fibrosis, collagen-I, detected with the use of stains such as Masson Trichrome. In addition to variability in 
staining technique, the method commonly suffers from a lag time of ~48 hours due to tissue processing. This delay 
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is undesirable, particularly in the setting of kidney transplantation, where the decision of accepting and implant-
ing a kidney allograft from a deceased donor depends on a rapid and on-site assessment of fibrosis. Moreover, 
an IFTA estimate is derived from 1–3 core biopsies of a kidney and is assumed for the entire kidney. This extrap-
olation introduces sampling error, as IFTA can be patchy within the kidney. While a determination of IFTA at 
multiple regions in renal parenchyma would provide a better estimate of the extent of renal damage, it is not fea-
sible with core biopsies because of the risk of bleeding induced by core biopsies6. Moreover, the semi-quantitative 
method currently used to measure fibrosis is subjective, quite imprecise and observer-dependent. Whereas inter-
stitial fibrosis measurements derived from detailed scoring systems, including whole-slide digital images of kid-
ney biopsies, have been shown to predict outcome7–9 this is time-, resource- and labor-intensive. Thus, there is an 
unmet need for a universal, minimally invasive, accurate, rapid, quantitative and standardized method for meas-
uring IFTA for routine clinical prognosis and to guide therapy and stratify subjects for interventional studies.
Optical technologies offer the potential to meet that need. To date, however, none of the published reports 
using optical technologies have focused on the potential for clinical translation. One group has recently shown 
that molecular vibrational spectroscopy can detect spectral changes associated with peptide modes in collagen 
(mainly C–O and C–O–C stretch modes), as indicative of increasing amounts of collagen10, but this method 
requires biopsy sample preparation for off-line infrared spectroscopic microscopy (analogous to histopathology 
but without staining) and cannot be used in real time or for in-vivo applications. Other optical methods that have 
been reported include fluorescence lifetime imaging11,12 and second-harmonic microscopy13,14, but these suffer 
from the same limitations, are very expensive, and do not offer clinical translation.
The method reported here, elastic-scattering spectroscopy (ESS) offers the potential for objective, quantitative, 
rapid, clinical application at low cost, based on optical measurements of unlabeled tissue. Bigio and colleagues 
developed the original methods of ESS, and demonstrated its clinical applications for noninvasive tissue diagno-
sis, based on the scattering properties of cellular and subcellular structures, predominantly for detecting cancer 
and pre-cancer. (See, for example, early demonstrations15–17) ESS has shown promise as a minimally-invasive tool 
for distinguishing a variety of disease pathologies in organs such as urinary bladder16, breast and associated lymph 
nodes18–20, prostate21, thyroid22,23 and pathologies in the GI tract, such as dysplasia in the esophagus24–28, polypoid 
neoplasia in colorectal cancer screening/surveillance29–32 and colitis and dysplasia in patients with IBD17,29,33.
Results
From among several available animal models of CKD, we examined ESS spectra in two well-established rodent 
models34,35, which are characterized predominantly by interstitial fibrosis and tubular atrophy (IFTA). The unilat-
eral ureteric obstruction (UUO) model, a model of obstructive nephropathy in humans, was generated by ligating 
the left ureter in a group of C57BL/6 male and female mice (Fig. 1A). As represented in Fig. 1B, groups of four 
mice were harvested at intervals of one week, for a total duration of four weeks. The renal function was measured 
by blood urea nitrogen (BUN), and the extent of IFTA was estimated on histology of the kidney tissue stained 
with Masson Trichrome stain.
The UUO model resulted in hydroureter and hydronephrosis on the left side with eventual thinning of the renal 
cortex (Fig. 1A). Blood urea nitrogen (BUN) levels were monitored weekly in mice to follow deterioration of renal 
function (Fig. 2A). While BUN levels were significantly higher in mice over a three-week period, compared to the 
control time, t = 0, the highest BUN was noted in the first week. The baseline average BUN (t = 0, average ± SEM) 
was 22.2 ± 4.2 mg/dl. BUN rose acutely and significantly in the first week post UUO to 96.1 ± 4.5 mg/dl; 
p < 0.05. This acute rise was followed by a reduction in the 2nd week post UUO to 63.7 ± 4.5 mg/dl, and then BUN 
stabilized in the range of 79.4–62.9 mg/dl for last 2 weeks. This pattern of rise and stabilization of BUN after the 
first week of ureteric ligation represents acute tubular injury during the early phase of obstruction, followed by 
compensatory hyper-functioning of the contralateral right kidney, as described by others36,37. The average dimen-
sion of kidneys in the UUO model varies depending on the time elapsed after ureter obstruction. The obstructed 
kidney undergoes enlargement due to backpressure changes associated with the ureteric ligation, followed by 
damage to the cortex resulting in a thin cortex. At the end of 4 weeks, the obstructed kidneys for the UUO model 
had sizes (measured as length) of 12–13.5 mm.
The obstructed kidneys showed progressive increase in IFTA over the entire duration of obstruction. The 
kidneys harvested at end of 7 days showed prominent dilatation of tubules and loss of brush border, damage of 
both the proximal and distal tubular cells, and interstitial infiltrates. These acute changes were replaced by loss of 
glomeruli, tubular atrophy, and loss of tubular mass on H& E staining in kidneys from later time points (Fig. 2B). 
Masson Trichrome stain showed increasing amounts of fibrosis, seen as blue-colored stain, and highest in the 
kidneys harvested at the later time points. The blue color in the Masson Trichrome stained section indicate the 
deposition of collagen in the renal interstitium. The IFTA was semi-quantitatively evaluated by a nephropathol-
ogist using standard assessment of Trichrome stain density and distribution, on a scale of 1–5, with the value of 5 
corresponding to IFTA of 100% of the parenchyma. This IFTA percentage exhibited a progressive increase with 
the duration of obstruction (Fig. 2C).
Using a fiberoptic probe, the ESS spectra for the UUO model were recorded from several points on the exter-
nal surface and from the inside of the bisected kidneys (Fig. 3A). The ESS method and the fiberoptic probe design 
are described in more detail in the Methods section. Briefly, a small fiberoptic handheld probe integrates two 
adjacent optical fibers, one for illumination (with a short pulse of broadband light) and the other for collecting 
some of the light backscattered from the tissue. When recording an ESS spectrum, the tip of the probe is placed in 
gentle contact with the tissue surface, and the backscattered light is collected and recorded with a spectrometer.
The spectra, as plotted, were normalized to the value of 1 at 650 nm, to enable comparison of spectral shapes, 
independent of overall amplitude (Fig. 3B). The familiar Soret- and Q-bands of hemoglobin optical absorption are 
seen (at ~420 and 540–580 nm); and the depth of these bands correlates with blood-volume fraction. However, 
given that these measurements were made ex-vivo, without active perfusion, we ignored this feature and sought 
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to address changes in optical diffuse reflectance as an indication of variations in the tissue scattering coefficient 
associated with relative amounts of collagen. Given the small dimensions of collagen fibrils38, increases in collagen 
content can be expected to enhance diffuse reflectance at shorter wavelengths, relative to longer wavelengths39. 
The readily-observed increases in optical reflectance at shorter wavelengths (350–550 nm) relative to the normal-
ization point (650 nm) were found to correlate monotonically with the degree of IFTA (Fig. 3B). For the analysis 
presented here, we chose (by inspection) the integrated area of the spectral range 350–450 nm as the optical 
biomarker for comparison with IFTA percentages from histopathology, given the stronger effects of scattering by 
collagen at shorter wavelengths.
Figure 1. (A) Schema of generation of the UUO model. (Upper panel) C57BL/6 mice underwent laparotomy 
to ligate left ureter, and were allowed to progress for times up to 4 weeks. The obstructed kidneys develop 
hydronephrosis and hydroureter, while the contralateral kidney hyperfunctions to compensate for the partial 
loss of functional renal mass. Lower panel left: displays the normal right kidney and left hydroureter and 
hydronephrotic (K) kidneys. Lower panel middle: shows the relative sizes of the obstructed kidney compared 
and the normal contralateral kidney. Lower panel right: the kidneys were sliced open at the hilum, and their 
internal surfaces are shown. The obstructed kidney is pale colored with thinner parenchyma. (B) Schema of 
experimental strategy. Two different models of CKD were performed. Fresh kidneys after harvest were subjected 
to ESS and then processed by formalin fixation and then stained using H& E and Trichrome. Blood was 
analyzed for BUN to assess renal function.
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Next, we confirmed the ESS spectral biomarker in another model of CKD. The adenine-diet-induced (AD) 
mouse model for CKD is a model of crystal-induced CKD in humans. It is characterized by increases in BUN and 
creatinine, hyperphosphatemia and systemic uremic toxicity, including secondary hyperparathyroidism, bone 
disease, and vascular calcification within two to four weeks of exposure to a diet supplemented with adenine40–43. 
Adenine is metabolized to 2,8-dihydroxyadenine and precipitates into crystals in the microvilli and apical epithe-
lial region of the proximal tubules, causing tubular damage and IFTA41. The adenine-diet model is characterized 
by profound fibrosis, and some reduction in the size of the kidney. Compared to the kidneys of mice on normal 
chow (length range ~9–10.5 mm), those on adenine chow had kidney lengths in the range 8–9 mm
We examined this model in the C57BL/6 mice and subsequently confirmed our findings in the 129/SvEv mice. 
The results for both strains were substantially the same, and in Fig. 4 we show the data from C57BL/6 mice, as 
exemplary of the two. This strategy was employed to rule out strain-specific differences in the susceptibility to 
adenine-induced injury and ESS changes. In both strains, the experimental group consisted of a combination of 
male and female mice and received a diet containing 0.25% adenine for one week followed by 0.2% adenine for 
three weeks, while mice on normal chow served as controls. In the C57/BL6 mice, the adenine-fed group exhib-
ited profound tubular atrophy, fibrosis, inflammatory cell infiltration, dilatation of tubules, intraluminal casts, 
all suggestive of loss of renal mass and IFTA (Fig. 4A). The IFTA percentages were significantly higher in the 
Figure 2. (A) Rise of BUN in animals with obstructed kidneys. Average BUN from four animals per time 
points is shown. Error bars = total range of values. (B) Kidney harvested from mice at every point were 
stained with Hematoxylin & Eosin (upper panel) and Trichrome stain (lower panel). Blue color of Trichrome 
stain corresponds to the fibrotic tissue. Gross specimens: scale bars = 1 cm. (C) IFTA percentage in UUO 
model. IFTA is represented as the percentage of tissue area showing fibrosis, as described in the Methods, as 
determined by a renal pathologist blinded to the sample. Average percentage per time-point (N = 4 animals/
time-point) is shown, along with all values for individual animals.
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adenine-fed group (Fig. 4B). Extensive renal damage was corroborated by a significant rise in BUN in the animals 
with adenine diet at t = 14 days. (Normal chow: BUN 20.30 ± 1.92 mg/dl; t = 14 days, BUN = 104.6 ± 4.10 mg/dl, 
p < 0.001) (Fig. 4C). The 129/Svev mice exhibited similar trends to the C57/BL6 on an adenine diet (data not 
shown). The ESS spectra obtained on these animals (Fig. 4D) differ in shape from those observed in the fibrotic 
kidneys of the UUO model – the two methods do not generate precisely the same pathology – but they also 
exhibit increased signal in the range 350–450 nm compared to the control. For the AD model, Fig. 4D displays 
ESS spectra from individual animals in the C57BL/6 group, to illustrate the degree of variance.
Figure 5 shows a scatter plot of the entire set of 40 animals, for both models (and both strains in the AD 
model), and the controls, comparing the ESS spectral biomarker (area under the curve from 350 to 450 nm) with 
the individual IFTA percentages derived from Masson Trichrome stain analysis by the nephropathologist. The 
computed correlation coefficient was r = 0.85, with a confidence interval [0.73. 0.92], and p-value, p ≪ 0.05.
Discussion
While these results constitute an encouraging proof-of-concept, our motivation for the application of ESS is 
two-fold. First, in the short-term, ESS can provide rapid, objective (quantitative) assessment of fibrosis on biopsied 
kidney tissue. This ex-vivo assessment will fit well within the current clinical work flow of the patient and has high 
potential for rapid adoption. Second, this ESS method offers the future potential to be leveraged for in-vivo determi-
nation of renal fibrosis by incorporating the probe into a fine-needle tool (25-gauge), which would enable real-time 
transdermal clinical assessment of CKD, but with lower trauma than for the typical large-core biopsy tool.
The current work examines changes in ESS spectra in fibrotic kidneys of animals in two discrete CKD rodent 
models; its broad applicability requires validation in other animal models of CKD representing different types of 
Figure 3. (A) Left: ESS spectra were obtained from a series of locations from outer surface of kidneys after 
removal of Gerota’s fascia. Right: The kidney was then sliced open (bisected), and ESS spectra were obtained 
from various locations of the cortex and medulla as shown. (B) Averaged spectra obtained from the inside 
(cortex and medulla) and surface of obstructed left kidney over four weeks duration are shown. Four animals 
per time point after induction of UUO model are compared with kidneys from control animals. The spectra are 
normalized at 650 nm to facilitate comparison of spectral shapes and relative spectral amplitudes at the shorter 
wavelengths.
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human CKD, and also in human kidneys with different degrees of fibrosis. Our future work will include careful 
spatial registration of measurement locations on kidney cores, to have pathology readings that are co-registered 
reliably with the corresponding ESS spectral patterns, enabling development of more specific quantitative spec-
tral biomarkers that correlate with staging of CKD. It is understood that perfusion will be different for ex-vivo vs 
Figure 4. (A) Extensive fibrosis in adenine-fed mice. Kidneys of C57BL/6 mice exposed to 0.25% Adenine diet 
for one week followed by 0.2% diet for one week are shown and compared to those on normal chow. Histology 
images of kidney tissue stained with Masson Trichrome are shown. Scale bar = 100 µm. (B) IFTA percentage 
in the AD model. A percentage of IFTA (determined by histopathology with Masson Thrichrome staining) 
as described in Methods, determined by a renal pathologist blinded to the sample. Average percentages 
for controls and 10 treated mice (N = 5, for each of two strains) at 14 days are shown. Values for individual 
animals shown, with some overlap. (C) Significant rise in BUN in adenine-diet animals. Average BUN from 
five C57BL/6 controls and five AD mice at 14 days are shown. Error bars = full range of vales. (D) Individual 
spectra from 5 control mice and 5 adenine-diet C57BL/6 mice at 14 days. The spectra are normalized at 650 nm 
to facilitate comparison of spectral shapes. (Spectra from the 129/SvEV strain, not shown, were essentially 
similar). We note that, although spectral trends in the range 350–450 nm are essentially similar to those in the 
UUO model, the AD model exhibits an absorption band at wavelengths below 350 nm. We have not identified 
the source of this absorption, although we speculate that this may be due to the dihydroxyadenine crystals that 
form in the kidney, and that exhibit strong absorption in the UV-B region.
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in-vivo measurements. This study was intended to provide motivation for potential future studies with in-vivo 
protocols. As such, we compared our results to histopathology, which is also conducted ex-vivo. The resulting data 
indicate dramatic spectral changes due to changes in the scattering properties of fibrotic renal tissue, independent 
of differences in Hb absorption.
The potential advantages over the current practice are substantial. The standard-of-care practice uses a large 
(~16-gauge) core-biopsy tool, with an OD of 1.65 mm, and it extracts a tissue sample that is ~1 mm in diameter 
and ~15 mm long, limited to the superficial cortex. Due to the tissue trauma caused by such large biopsy tools, 
there is a substantial risk of bleeding; post-biopsy ultrasound frequently documents hematoma adjacent to the 
kidney6. Therefore, such cores are employed sparingly (typically 2–3 cores), which limits the areas and depth of 
kidney that can be sampled, a major limitation. In the future, once proven, attempts can be made to perform 
ESS measurements within the renal parenchyma using a 25-gauge ESS probe (0.51 mm diameter). While this 
method only partially circumvents the problem related sampling, such a technique may obviate the need for an 
excised tissue sample for diagnosis of IFTA, and can be expected to exhibit a dramatic reduction in tissue trauma 
and bleeding44, enabling more extensive sampling along a larger number of tracks, over the full length of each 
track, traversing from superficial cortex to deep medulla. The ESS spectrum is also sensitive to the strong absorp-
tion by oxy-/deoxy-hemoglobin, which provides additional diagnostic information, as the status of hemoglobin 
is dependent on renal perfusion: capillary rarefaction observed with renal fibrosis compromises the perfusion 
within renal parenchyma45–48. Thus, in addition to the spectral biomarkers for quantitative assessment of fibrosis, 
the changes in oxy-/deoxy-hemoglobin are likely to alter the ESS spectra acquired interstitially, and this can be 
used as an informative parameter to estimate renal parenchymal perfusion49,50.
Finally, we wish to note that fibrosis also figures prominently as a threatening factor associated with a num-
ber of other tissue pathologies, prominent among them being idiopathic pulmonary fibrosis (IPF)51. Traditional 
imaging methods are often unable to distinguish IPF from other lung abnormalities52, leading to the requirement 
for invasive surgical biopsy. Variations of the method reported here could enable low-cost, noninvasive and quan-
titative diagnosis of IPF, by optical measurements mediated by the new generation of smaller bronchoscopes that 
reach into more distal pulmonary branches53,54.
In summary, IFTA is the critical component of renal biopsy evaluation that has profound clinical impli-
cations for a patient from prognostic perspective and for therapeutic decision. The current gold-standard for 
IFTA evaluation has several limitations especially in certain clinical scenarios, such as donor kidney evaluation 
for the cadaver transplantation. Hence, developing rapid orthogonal techniques with high accuracy is imper-
ative. While the current body of work illustrates a simplified differentiating biomarker extracted from the ESS 
spectra, it provides impetus for continued elaboration of the methods, for which we will develop rigorous 
algorithms based on the rich information content of the entire ESS spectral pattern, enabling development 
of quantitative morphometric indices of clinically relevant biomarkers for disease. In short, ESS has potential 
to address several limitations of the current standard-of-care. It indeed enables faster and more quantitative 
assessment of IFTA in extracted tissue, and, has the future potential for immediate bedside assessment of 
fibrosis and tubular atrophy.
Figure 5. Comparison of the degree of IFTA from histopathology of all mice, presented as individual 
points, against a simplified ESS spectral feature chosen by inspection (the relative areas under the curve of 
the spectra from 350 to 450 nm). IFTA assessment of the stained kidney slides was performed by an expert 
nephropathologist, and is expressed as a percentage of total kidney area that was affected. Data are displayed for 
all time-points of the UUO model, together with the data of the AD model (at 14 days). Controls (untreated) for 
both models are represented by the triangles (and evidenced no significant difference between the two strains 
used in the AD model). Computed correlation coefficient: r = 0.85; confidence interval [0.73. 0.92]; p-value, 
p ≪ 0.05.
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Methods
Brief description of elastic-scattering spectroscopy (ess). Earlier applications of ESS addressed epi-
thelial pathologies (pre-cancer and early cancer), wherein alterations in the cellular and sub-cellular architecture 
and ultrastructure are responsible for the changes in ESS spectra. Similarly, alterations in the extracellular matrix 
also affect the wavelength-dependence of elastically-scattered light, enabling ESS to be responsive to varying 
amounts of fibrosis. The main elements of the ESS method and instrumentation have been described in a number 
of earlier publications17,55–58.
In these implementations, ESS is an instant point-spectroscopic measurement technique, not an imaging 
modality, which measures the spectrum of backscattered light from tissue near the probe tip, over a broad wave-
length range (320–900 nm in our current system), using a fiberoptic geometry that enhances sensitivity to the 
cellular and tissue architecture, and micromorphology of ECM structures. ESS is a form of sub-diffuse reflectance 
spectroscopy, specifically (and importantly) at very small source-detector separations (here, ~150 μm), for which 
the diffusion equation is not valid, and sensitivity to the scattering phase function is enhanced. In various clinical 
implementations, the tip of the probe (invoking separate illuminating and collecting fibers) is either in optical 
contact with the surface of the tissue under examination (Fig. 6A), or integrated into a fine needle and inserted 
into the parenchyma of solid organs (Fig. 6B). When performed with this optical geometry, ESS is sensitive to 
the absorption spectra of strong chromophores (e.g. oxy-/deoxy- hemoglobin) but, more importantly, measures 
scattering properties, such that the spectral features relate to sub-cellular structural features, as well as structures 
of the extracellular matrix.
The ESS control system is small (as small as a box of tissues), portable, and can be easily carried into the clinic. 
The light source is a pulsed (~20 μsec) xenon short-arc lamp (Hamamatsu, Inc.) and it is coupled to the illumi-
nation fiber. The CCD detector array (Hamamtsu, Inc.) in the spectrometer has a fast electronic shutter, enabling 
fast gating of the spectral measurement, which minimizes the effects of background light. Diffusely reflected light 
from the tissue is transmitted by the collection fiber and coupled directly to the entrance slit of the spectrometer. 
The fiberoptic probe used in these studies (Fig. 6) consisted of a 150-μm-core diameter illumination fiber and 
an adjacent 100-μm-diameter collection fiber, with center-to center separation of ~150 microns. For the ex-vivo 
measurements reported here, the diameter of the outer tubing of the fiberoptic handpiece was ~1 mm. (In future 
studies of in-vivo, transcutaneous measurements, smaller fibers will be incorporated into a 25-gauge fine needle, 
to minimize tissue trauma).
Prior to recording spectra from the tissue, a calibration spectrum from a spectrally-flat diffuse reflection 
standard (SpectralonTM: Labsphere, Inc.) is taken, I(λ)ref. The diffuse reflectance of this reference material is spec-
trally flat when measured at a short distance from the surface (>98% over the full spectral range of the ESS meas-
urement). The reference spectrum is used to account for any spectral variations in the light source, spectrometer, 
fiber transmission and fiber coupling. All spectra in this study were recorded as ratios of the tissue spectrum to 
Figure 6. Diagrammatic representation of two options for the ESS fiberoptic probe geometry. (A) a square-
ended probe for measurements at the surface of a tissue; (B) fiberoptic probe integrated into a fine needle for 
measurements inside solid organs. In this study, all of the data presented were generated with the geometry for 
surface interrogation. In future studies, especially for transdermal implementation, the needle geometry can be 
integrated with a long 25-gauge fine needle, to minimize tissue trauma.
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the reference spectrum, providing spectra that are independent of the spectral response of the system. As such, 
the optical system, including the probe, was calibrated at the time of the measurement, and the tip of the probe 
was then placed in contact with the tissue site to be investigated. Spectral measurements were triggered by the 
use of either a foot pedal or the keyboard on the integrated computer. Even though the fast optical gating of the 
detector results in minimal effects of background light, the instrumentation compensates for any background 
light (and electronic detector offset) by taking an initial measurement without firing the xenon lamp [I(λ)tissue 
background or I(λ)ref background] followed immediately by a subsequent reference or tissue measurement with the pulsed 
lamp triggered. The calculated ESS spectra are the result of the subtraction of the background spectrum from the 
tissue or reference spectrum. Thus, calibrated spectra were calculated according to:
I
I I
I I
( )
( ) ( )
( ) ( )
tissue tissue background
ref ref background
λ
λ λ
λ λ
=
−
−
Calculation of spectral biomarker. The spectra were all normalized to a value 1 at 650 nm, and the area of 
the spectrum from 350–450 nm was determined simply by adding the values of all the pixels in that range. Given 
the normalization, spectral area values are relative and can be scaled arbitrarily for presentation.
Animal models for chronic kidney disease. All the experiments were conducted after approval of the 
Institutional Animal Care and Use Committee of Boston University School of Medicine. (IACUC approved pro-
tocol # AN-15449) All methods were performed in accordance with the relevant guidelines and regulations estab-
lished by that governing committee.
UUO model. Briefly, a group of 12-week-old C57BL/6 mice underwent laparotomy, and the left ureter was 
ligated close to the bladder. Four animals were sacrificed once a week for 4 weeks (plus time t = 0), and both the 
obstructed and the contralateral kidneys were isolated. The kidneys were sliced through the hilum along their ver-
tical axes. The ESS spectra were obtained using the fiberoptic probe on several points on the surface, cortex and 
the medulla of the kidneys. ESS spectra obtained from time t = 0 served as controls. After ESS measurements, the 
sliced kidneys were paraffin-embedded and stained with Masson Trichrome, which stains extracellular matrix, 
especially collagen-I.
The adenine-diet-induced (AD) mouse model. A group of both C57BL/6 and 129/SvEv strains of male and female 
mice (n = 10) was fed with a customized diet containing normal chow (Teklad Global 18% Protein Rodent Diet) 
mixed with 0.25% adenine (Research Diets, NJ) for one week followed by 0.20% diet for 3 weeks59. A separate 
group (n = 10) on normal chow served as controls. After euthanasia, the kidneys and blood were processed and 
ESS measurements taken, as described above.
Histological evaluation. Hematoxylin & Eosin and Masson Trichrome stains were performed on the slides 
in the Histopathology core at Boston University Medical Center. The slides were evaluated by a nephropathologist 
for the following features.
Tubulointerstitial: tubular atrophy, dilatation, casts, interstitial inflammation, and fibrosis as parameters of 
interstitial damage were determined using a semi-quantitative IFTA scoring method on PAS stained sections. 
IFTA Grade 0 indicates no changes; grade 1, lesions involving less than 25%; grade 2, lesions affecting 25–50%; 
and grade 3, affecting 50–75%; grade 4 lesions involving more than 75% of the field60–62.
Data Availability
The spectral files reported and analyzed in this report are available to academic researchers upon request to the 
corresponding author.
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